查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2102371

口服益生菌產品市場：預測至2034年－按產品類型、益生菌菌株、應用、通路、最終用戶和地區分類的全球分析

Oral Probiotic Products Market Forecasts to 2034 - Global Analysis By Product Type, Probiotic Strain, Application, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，預計到 2026 年，全球口服益生菌市場將達到 39 億美元，並在預測期內以 10.2% 的複合年成長率成長，到 2034 年達到 70 億美元。

口腔益生菌是含有活性有益微生物的消費保健產品，這些微生物經過精心挑選和配製，能夠定植於口腔，維護牙齒和牙周組織的健康。這些產品含有多種菌株，例如羅伊氏乳桿菌、副乾酪乳桿菌、唾液鏈球菌、雙叉桿菌和鼠李糖乳桿菌，它們能夠與病原體競爭附著位點，並產生抗菌物質。產品線包括益生菌錠劑、口香糖、牙膏、漱口水、片劑和粉劑，旨在融入日常口腔衛生習慣中。口腔益生菌的生產過程受到嚴格的品管，以確保菌株的活性、菌落形成單位 (CFU) 計數的準確性以及在整個保存期限內的穩定性。它們有助於消費者透過預防性措施來維持口腔微生物群的平衡，並降低齲齒、牙齦炎和口臭的風險。

口腔微生物組研究

隨著人們對口腔微生物群在整體健康中作用的科學認知不斷加深，消費者和專業人士對益生菌口腔清潔用品解決方案的興趣顯著提升。研究顯示口腔細菌與心血管疾病、糖尿病和呼吸系統疾病之間存在關聯，這使得口腔健康不再只是美容問題，而是成為一項至關重要的健康議題。牙科專業人士擴大推薦益生菌產品作為傳統口腔衛生方案的輔助性治療。牙醫協會和醫療機構所進行的消費者宣傳宣傳活動提高了大眾對抗菌漱口水限制的認知，因為抗菌漱口水可能會破壞有益的口腔微生物群。臨床試驗結果的發表證實了特定益生菌菌株在預防齲齒和維護牙齦健康方面的有效性，這些結果為益生菌產品提供了循證依據，使其價格合理，並獲得了專業人士的推薦。

與應變穩定性相關的挑戰

在整個生產、分銷和儲存過程中保持益生菌菌株的活性，一直是口服益生菌產品生產商面臨的持續的技術和經濟挑戰。活微生物對溫度波動、濕度和氧氣水平非常敏感，這些因素都會導致產品在被消費者服用前菌落形成單位（CFU）數量減少。這就需要專門的低溫運輸物流和保護性包裝，從而增加生產成本，最終反映在零售價格上。如果穩定性測試方案不完善，則產品標籤上準確顯示活菌數量的監管要求會帶來合規風險。消費者對正確儲存條件的誤解會導致產品劣化和功效降低，進而造成不良的使用者體驗，並促使消費者轉換其他品牌。

牙科專家頻道

將口腔益生菌產品整合到建議的牙科診療方案中，蘊藏著巨大且尚未開發的成長潛力。牙科保健員和牙周病醫師在日常檢查和治療諮詢中，擁有獨特的優勢，能夠影響患者的購買決策。專業級益生菌配方，具有高菌濃度和經臨床驗證的療效，可透過處方箋和診所內部配藥模式獲得高價。益生菌生產商與牙科診所網路之間的夥伴關係項目，既能改善患者的治療效果，又能創造互惠互利的收入來源。持續教育舉措，例如針對牙科專業人員的微生物組科學和益生菌作用機制的培訓，能夠幫助他們建立必要的知識基礎，從而更有信心地推薦產品。

抗菌劑的替代品

先進抗菌肽、噬菌體療法和益生元化合物的研發對益生菌為基礎的口腔清潔用品解決方案構成了新的競爭威脅。這些替代技術能夠消除目標病原體，而無需像益生菌產品那樣面臨活性細菌穩定性所帶來的限制。製藥公司正在投資研發可核准上市的口腔微生物組調節方法，並聲稱其臨床療效優於核准上市的膳食補充劑。消費者對即時緩解症狀的偏好可能促使他們選擇速效抗菌產品，而非益生菌所需的緩慢起效過程。奈米技術與口腔護理科學的融合有望創造出新一代產品，在功效和便利性方面超越現有的益生菌製劑。

新型冠狀病毒（COVID-19）的影響：

新冠疫情提高了人們對口腔健康與全身免疫功能之間關聯的認知，進而引發了對口腔益生菌產品日益成長的興趣。初期，供應鏈中斷尤其影響了進口菌株的生產和分銷。然而，人們對個人衛生和預防醫學的日益重視帶來了持久的行為改變，從而對該品類產生了積極影響。疫情過後，消費者對微生物群平衡和天然預防方法的關注度依然很高。隨著牙科診所重新開放和預防保健流程的恢復，專業推薦管道也逐漸恢復正常。

在預測期內，益生菌錠劑細分市場預計將佔據最大的市場佔有率。

由於其最佳的服用方式，益生菌錠劑預計將在預測期內佔據最大的市場佔有率。這種服用方式能夠最大限度地延長口腔接觸時間，並提高菌株的定植效率。錠劑在口腔中緩慢溶解，使有益菌能夠長時間與口腔表面接觸，從而粘附並形成菌落。這種劑型與潤喉糖和口氣清新劑類似，降低了消費者接受的門檻。領先的益生菌生產商正在開發更佳的配方，使用天然香料來減輕活菌特有的味道。錠劑包裝便於攜帶且隱蔽，適合外出時使用。此外，兒童配方的出現也拓展了市場，使更多家長能夠為孩子尋找預防齲齒的方案。

在預測期內，多菌株產品細分市場預計將呈現最高的複合年成長率。

在預測期內，多菌株產品細分市場預計將呈現最高的成長率，這主要得益於科學證據表明，多樣化的細菌群落比單一菌株產品更能有效地支持口腔微生物組的健康。多菌株組合能夠同時靶向多種致病菌，並在口腔環境中產生協同的生態學效應。先進的生產技術提高了混合菌株在生產和儲存過程中的穩定性。消費者對微生物組多樣性的認知提升，也推動了對綜合益生菌解決方案的需求。牙科研究表明，多菌株方案能夠帶來更優的臨床療效，這為專家建議提供了支持。多菌株產品的高階定位和更高的價格也促進了其銷售的加速成長。

市佔率最大的地區：

在預測期內，北美預計將佔據最大的市場佔有率，這主要得益於該地區民眾對口腔衛生的高度重視以及眾多益生菌研發和生產企業的聚集。美國憑藉其完善的牙科保健體系和消費者在預防性保健產品上的強勁支出，引領市場。 Church & Dwight Co., Inc.、高露潔棕欖公司和強生公司等領導企業正在推動創新和分銷。該地區先進的膳食補充劑法規結構為益生菌產品的開發提供了清晰的路徑。牙科保險對預防保健的覆蓋範圍擴大，促進了定期專業護理的開展，而這些護理通常會建議使用益生菌。

複合年成長率最高的地區：

在預測期內，亞太地區預計將呈現最高的複合年成長率，這主要得益於口腔衛生意識的提高以及中國、日本和印度中產階級的壯大。該地區傳統的發酵食品文化使消費者熟悉了有益菌的概念。快速的都市化和西式飲食習慣的普及導致牙科疾病的盛行率上升，從而催生了對預防性解決方案的需求。政府進行的公共衛生宣傳活動正在加速意識提升，並推動消費者教育的普及。現代零售和電子商務通路的擴張也改善了以往服務不足的市場的產品取得途徑。

免費客製化服務：

所有購買此報告的客戶均可享受以下免費自訂選項之一：

  • 企業概況
    • 對其他市場參與者（最多 3 家公司）進行全面分析
    • 對主要公司進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，我們可以提供主要國家的市場估算和預測，以及複合年成長率（註：需經可行性確認）。
  • 競爭性標竿分析
    • 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

目錄

第1章執行摘要

  • 市場概覽及主要亮點
  • 促進因素、挑戰與機遇
  • 競爭格局概述
  • 戰略洞察與建議

第2章：研究框架

  • 研究目標和範圍
  • 相關人員分析
  • 研究假設和限制
  • 調查方法

第3章 市場動態與趨勢分析

  • 市場定義與結構
  • 主要市場促進因素
  • 市場限制與挑戰
  • 投資成長機會和重點領域
  • 產業威脅與風險評估
  • 技術與創新展望
  • 新興市場/高成長市場
  • 監管和政策環境
  • 新冠疫情的影響及復甦前景

第4章：競爭環境與策略評估

  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭公司之間的競爭
  • 主要公司市佔率分析
  • 產品基準評效和效能比較

第5章 全球口服益生菌產品市場：依產品類型分類

  • 益生菌錠劑
  • 益生菌口香糖
  • 益生菌牙膏
  • 益生菌漱口水
  • 益生菌片
  • 益生菌粉

第6章 全球口服益生菌市場：依益生菌菌株分類

  • 羅伊氏乳桿菌
  • 副乾酪乳桿菌
  • 唾液鏈球菌
  • 乳酸雙叉桿菌桿菌
  • 鼠李糖乳桿菌
  • 多菌株組合產品

第7章 全球口腔益生菌市場：依應用分類

  • 口腔衛生
  • 牙齦健康
  • 預防蛀牙
  • 口臭治療方法
  • 免疫支持
  • 牙科術後護理

第8章 全球口服益生菌產品市場：依通路分類

  • 藥局/藥局
  • 超級市場和大賣場
  • 專業健康食品店
  • 電子商務平台
  • 牙醫診所
  • D2C

第9章 全球口服益生菌市場：依最終用戶分類

  • 孩子們
  • 成人
  • 老年人
  • 正畸患者
  • 牙科護理患者
  • 一般消費者

第10章 全球口服益生菌產品市場：依地區分類

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 比利時
    • 瑞典
    • 瑞士
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 馬來西亞
    • 新加坡
    • 越南
    • 其他亞太國家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
    • 智利
    • 秘魯
    • 其他南美國家
  • 世界其他地區（RoW）
    • 中東
      • 沙烏地阿拉伯
      • 阿拉伯聯合大公國
      • 卡達
      • 以色列
      • 其他中東國家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲國家

第11章 策略市場資訊

  • 工業價值網路和供應鏈評估
  • 空白區域和機會地圖
  • 產品演進與市場生命週期分析
  • 通路、經銷商和打入市場策略的評估

第12章 產業趨勢與策略舉措

  • 併購
  • 夥伴關係、聯盟和合資企業
  • 新產品發布和認證
  • 擴大生產能力和投資
  • 其他策略舉措

第13章：公司簡介

  • Sunstar Suisse SA
  • Koninklijke DSM-Firmenich NV
  • Kerry Group plc
  • Chr. Hansen Holding A/S
  • Lallemand Inc.
  • BioGaia AB
  • Probi AB
  • Oragenics, Inc.
  • Dentaid SL
  • Church & Dwight Co., Inc.
  • Haleon plc
  • Colgate-Palmolive Company
  • Lion Corporation
  • Johnson & Johnson
  • Nestle Health Science
  • DuPont Nutrition & Biosciences
  • Oral Biotech Ltd.
Product Code: SMRC38277

According to Stratistics MRC, the Global Oral Probiotic Products Market is accounted for $3.9 billion in 2026 and is expected to reach $7.0 billion by 2034 growing at a CAGR of 10.2% during the forecast period. Oral probiotic products refer to consumer health products containing live beneficial microorganisms specifically selected and formulated to colonize the oral cavity and support dental and periodontal health. These products incorporate strains such as Lactobacillus reuteri, Lactobacillus paracasei, Streptococcus salivarius, Bifidobacterium lactis, and Lactobacillus rhamnosus that compete with pathogenic bacteria for adhesion sites and produce antimicrobial substances. The product range includes probiotic lozenges, chewing gums, toothpastes, mouthwashes, tablets, and powders designed for daily oral hygiene integration. Oral probiotic products are manufactured under strict quality controls to ensure strain viability, accurate colony-forming unit counts, and stability throughout shelf life. They serve consumers seeking preventive approaches to maintaining balanced oral microbiomes and reducing the risk of dental caries, gingivitis, and halitosis.

Market Dynamics:

Driver:

Oral microbiome research

Expanding scientific understanding of the oral microbiome's role in systemic health is driving significant consumer and professional interest in probiotic oral care solutions. Research demonstrating connections between oral bacteria and cardiovascular disease, diabetes, and respiratory conditions has elevated oral health from a cosmetic concern to a critical wellness priority. Dental professionals increasingly recommend probiotic products as adjunctive therapies alongside conventional oral hygiene protocols. Consumer awareness campaigns by dental associations and healthcare organizations have educated populations about the limitations of antibacterial mouthwashes in disrupting beneficial oral flora. The publication of clinical trials validating specific probiotic strains for cavity prevention and gum health has provided evidence-based credibility that supports premium pricing and professional endorsement.

Restraint:

Strain stability challenges

Maintaining probiotic strain viability throughout manufacturing, distribution, and storage presents persistent technical and economic challenges for oral probiotic product manufacturers. Live microorganisms are sensitive to temperature fluctuations, moisture exposure, and oxygen levels that compromise colony-forming unit counts before product consumption. The need for specialized cold chain logistics and protective packaging increases production costs that are ultimately reflected in retail pricing. Regulatory requirements for accurate live bacteria counts on product labels create compliance risks if stability testing protocols are inadequate. Consumer misunderstanding about proper storage conditions leads to product degradation and suboptimal efficacy, generating negative user experiences and brand switching behavior.

Opportunity:

Dental professional channels

The integration of oral probiotic products into dental practice recommendation protocols represents a substantial untapped growth opportunity with high credibility impact. Dental hygienists and periodontists are uniquely positioned to influence patient purchasing decisions during routine checkups and treatment consultations. Professional-grade probiotic formulations with higher strain concentrations and clinical validation can command premium pricing through prescription and dental office dispensing models. Partnership programs between probiotic manufacturers and dental practice networks create mutually beneficial revenue streams while improving patient outcomes. Continuing education initiatives that train dental professionals on microbiome science and probiotic mechanisms build the knowledge base necessary for confident product recommendation.

Threat:

Antimicrobial alternatives

The development of advanced antimicrobial peptides, bacteriophage therapies, and prebiotic compounds presents emerging competitive threats to probiotic-based oral care solutions. These alternative technologies offer targeted pathogen elimination without the live organism stability challenges that constrain probiotic product efficacy. Pharmaceutical companies are investing in oral microbiome modulation approaches that may achieve regulatory drug status with stronger clinical claims than dietary supplement positioning allows. Consumer preference for immediate symptom relief may favor fast-acting antimicrobial products over the gradual colonization benefits that probiotics require. The convergence of nanotechnology and oral care science could produce next-generation products that outperform current probiotic formulations in both efficacy and convenience.

Covid-19 Impact:

The COVID-19 pandemic heightened awareness of the connection between oral health and overall immune function, driving increased interest in oral probiotic products. Initial supply chain disruptions affected manufacturing and distribution, particularly for imported strains. However, the emphasis on personal hygiene and preventive health created lasting behavioral changes that benefited the category. Post-pandemic, consumers maintain elevated attention to microbiome balance and natural preventive approaches. Dental practice reopenings and resumed preventive care routines have normalized professional recommendation channels.

The probiotic lozenges segment is expected to be the largest during the forecast period

The probiotic lozenges segment is expected to account for the largest market share during the forecast period, due to optimal delivery mechanics that maximize oral contact time and strain colonization efficacy. Lozenges dissolve slowly in the mouth, providing extended exposure of beneficial bacteria to oral surfaces where they can adhere and establish colonies. The format is familiar to consumers of throat lozenges and breath fresheners, reducing adoption barriers. Major probiotic manufacturers have developed pleasant-tasting formulations with natural flavors that mask the characteristic taste of live cultures. The portability and discretion of lozenge packaging support on-the-go consumption patterns. Pediatric-friendly formulations have expanded market reach to parents seeking cavity prevention solutions for children.

The multi-strain formulations segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the multi-strain formulations segment is predicted to witness the highest growth rate, driven by scientific evidence that diverse bacterial communities provide more robust oral microbiome support than single-strain products. Multi-strain combinations target multiple pathogenic species simultaneously while creating synergistic ecological benefits within the oral environment. Advanced manufacturing technologies have improved the stability of mixed-strain populations during production and shelf life. Consumer education about microbiome diversity has elevated demand for comprehensive probiotic solutions. Dental research demonstrating superior clinical outcomes with multi-strain protocols supports professional recommendations. Premium positioning and higher price points of multi-strain products contribute to revenue growth acceleration.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, due to high oral health awareness and the presence of major probiotic research and manufacturing companies. The United States leads with an established dental care infrastructure and strong consumer spending on preventive health products. Major companies, including Church & Dwight Co., Inc., Colgate-Palmolive Company, and Johnson & Johnson, drive innovation and distribution. The region's advanced regulatory framework for dietary supplements provides clear pathways for probiotic product development. Dental insurance coverage for preventive care supports routine professional engagement where probiotic recommendations occur.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to rising oral health awareness and expanding middle-class populations across China, Japan, and India. Traditional fermented food cultures in the region have established consumer familiarity with beneficial bacteria concepts. Rapid urbanization and Western dietary patterns have increased dental disease prevalence, creating demand for preventive solutions. Government public health campaigns promoting oral hygiene awareness accelerate consumer education. The expansion of modern retail and e-commerce channels improves product accessibility in previously underserved markets.

Key players in the market

Some of the key players in Oral Probiotic Products Market include Sunstar Suisse S.A., Koninklijke DSM-Firmenich N.V., Kerry Group plc, Chr. Hansen Holding A/S, Lallemand Inc., BioGaia AB, Probi AB, Oragenics, Inc., Dentaid S.L., Church & Dwight Co., Inc., Haleon plc, Colgate-Palmolive Company, Lion Corporation, Johnson & Johnson, Nestle Health Science, DuPont Nutrition & Biosciences and Oral Biotech Ltd.

Key Developments:

In June 2026, BioGaia AB launched a next-generation oral probiotic lozenge featuring patented Lactobacillus reuteri strains with enhanced adhesion properties for improved colonization efficacy.

In May 2026, Chr. Hansen Holding A/S introduced a multi-strain oral probiotic tablet combining five clinically validated bacterial strains for comprehensive gum health and cavity prevention support.

In April 2026, Colgate-Palmolive Company expanded its oral care portfolio with a probiotic mouthwash formulation designed to complement existing toothpaste and flossing routines for daily microbiome balance.

Product Types Covered:

  • Probiotic Lozenges
  • Probiotic Chewing Gums
  • Probiotic Toothpastes
  • Probiotic Mouthwashes
  • Probiotic Tablets
  • Probiotic Powders

Probiotic Strains Covered:

  • Lactobacillus reuteri
  • Lactobacillus paracasei
  • Streptococcus salivarius
  • Bifidobacterium lactis
  • Lactobacillus rhamnosus
  • Multi-Strain Formulations

Applications Covered:

  • Oral Hygiene
  • Gum Health
  • Cavity Prevention
  • Bad Breath Management
  • Immune Support
  • Post-Dental Treatment Care

Distribution Channels Covered:

  • Pharmacies and Drug Stores
  • Supermarkets and Hypermarkets
  • Specialty Health Stores
  • E-Commerce Platforms
  • Dental Clinics
  • Direct-to-Consumer (DTC)

End Users Covered:

  • Children
  • Adults
  • Geriatric Population
  • Orthodontic Patients
  • Dental Care Patients
  • General Consumers

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Oral Probiotic Products Market, By Product Type

  • 5.1 Probiotic Lozenges
  • 5.2 Probiotic Chewing Gums
  • 5.3 Probiotic Toothpastes
  • 5.4 Probiotic Mouthwashes
  • 5.5 Probiotic Tablets
  • 5.6 Probiotic Powders

6 Global Oral Probiotic Products Market, By Probiotic Strain

  • 6.1 Lactobacillus reuteri
  • 6.2 Lactobacillus paracasei
  • 6.3 Streptococcus salivarius
  • 6.4 Bifidobacterium lactis
  • 6.5 Lactobacillus rhamnosus
  • 6.6 Multi-Strain Formulations

7 Global Oral Probiotic Products Market, By Application

  • 7.1 Oral Hygiene
  • 7.2 Gum Health
  • 7.3 Cavity Prevention
  • 7.4 Bad Breath Management
  • 7.5 Immune Support
  • 7.6 Post-Dental Treatment Care

8 Global Oral Probiotic Products Market, By Distribution Channel

  • 8.1 Pharmacies and Drug Stores
  • 8.2 Supermarkets and Hypermarkets
  • 8.3 Specialty Health Stores
  • 8.4 E-Commerce Platforms
  • 8.5 Dental Clinics
  • 8.6 Direct-to-Consumer (DTC)

9 Global Oral Probiotic Products Market, By End User

  • 9.1 Children
  • 9.2 Adults
  • 9.3 Geriatric Population
  • 9.4 Orthodontic Patients
  • 9.5 Dental Care Patients
  • 9.6 General Consumers

10 Global Oral Probiotic Products Market, By Geography

  • 10.1 North America
    • 10.1.1 United States
    • 10.1.2 Canada
    • 10.1.3 Mexico
  • 10.2 Europe
    • 10.2.1 United Kingdom
    • 10.2.2 Germany
    • 10.2.3 France
    • 10.2.4 Italy
    • 10.2.5 Spain
    • 10.2.6 Netherlands
    • 10.2.7 Belgium
    • 10.2.8 Sweden
    • 10.2.9 Switzerland
    • 10.2.10 Poland
    • 10.2.11 Rest of Europe
  • 10.3 Asia Pacific
    • 10.3.1 China
    • 10.3.2 Japan
    • 10.3.3 India
    • 10.3.4 South Korea
    • 10.3.5 Australia
    • 10.3.6 Indonesia
    • 10.3.7 Thailand
    • 10.3.8 Malaysia
    • 10.3.9 Singapore
    • 10.3.10 Vietnam
    • 10.3.11 Rest of Asia Pacific
  • 10.4 South America
    • 10.4.1 Brazil
    • 10.4.2 Argentina
    • 10.4.3 Colombia
    • 10.4.4 Chile
    • 10.4.5 Peru
    • 10.4.6 Rest of South America
  • 10.5 Rest of the World (RoW)
    • 10.5.1 Middle East
      • 10.5.1.1 Saudi Arabia
      • 10.5.1.2 United Arab Emirates
      • 10.5.1.3 Qatar
      • 10.5.1.4 Israel
      • 10.5.1.5 Rest of Middle East
    • 10.5.2 Africa
      • 10.5.2.1 South Africa
      • 10.5.2.2 Egypt
      • 10.5.2.3 Morocco
      • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

  • 11.1 Industry Value Network and Supply Chain Assessment
  • 11.2 White-Space and Opportunity Mapping
  • 11.3 Product Evolution and Market Life Cycle Analysis
  • 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

  • 12.1 Mergers and Acquisitions
  • 12.2 Partnerships, Alliances, and Joint Ventures
  • 12.3 New Product Launches and Certifications
  • 12.4 Capacity Expansion and Investments
  • 12.5 Other Strategic Initiatives

13 Company Profiles

  • 13.1 Sunstar Suisse S.A.
  • 13.2 Koninklijke DSM-Firmenich N.V.
  • 13.3 Kerry Group plc
  • 13.4 Chr. Hansen Holding A/S
  • 13.5 Lallemand Inc.
  • 13.6 BioGaia AB
  • 13.7 Probi AB
  • 13.8 Oragenics, Inc.
  • 13.9 Dentaid S.L.
  • 13.10 Church & Dwight Co., Inc.
  • 13.11 Haleon plc
  • 13.12 Colgate-Palmolive Company
  • 13.13 Lion Corporation
  • 13.14 Johnson & Johnson
  • 13.15 Nestle Health Science
  • 13.16 DuPont Nutrition & Biosciences
  • 13.17 Oral Biotech Ltd.

List of Tables

  • Table 1 Global Oral Probiotic Products Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Oral Probiotic Products Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Oral Probiotic Products Market Outlook, By Probiotic Lozenges (2023-2034) ($MN)
  • Table 4 Global Oral Probiotic Products Market Outlook, By Probiotic Chewing Gums (2023-2034) ($MN)
  • Table 5 Global Oral Probiotic Products Market Outlook, By Probiotic Toothpastes (2023-2034) ($MN)
  • Table 6 Global Oral Probiotic Products Market Outlook, By Probiotic Mouthwashes (2023-2034) ($MN)
  • Table 7 Global Oral Probiotic Products Market Outlook, By Probiotic Tablets (2023-2034) ($MN)
  • Table 8 Global Oral Probiotic Products Market Outlook, By Probiotic Powders (2023-2034) ($MN)
  • Table 9 Global Oral Probiotic Products Market Outlook, By Probiotic Strain (2023-2034) ($MN)
  • Table 10 Global Oral Probiotic Products Market Outlook, By Lactobacillus reuteri (2023-2034) ($MN)
  • Table 11 Global Oral Probiotic Products Market Outlook, By Lactobacillus paracasei (2023-2034) ($MN)
  • Table 12 Global Oral Probiotic Products Market Outlook, By Streptococcus salivarius (2023-2034) ($MN)
  • Table 13 Global Oral Probiotic Products Market Outlook, By Bifidobacterium lactis (2023-2034) ($MN)
  • Table 14 Global Oral Probiotic Products Market Outlook, By Lactobacillus rhamnosus (2023-2034) ($MN)
  • Table 15 Global Oral Probiotic Products Market Outlook, By Multi-Strain Formulations (2023-2034) ($MN)
  • Table 16 Global Oral Probiotic Products Market Outlook, By Application (2023-2034) ($MN)
  • Table 17 Global Oral Probiotic Products Market Outlook, By Oral Hygiene (2023-2034) ($MN)
  • Table 18 Global Oral Probiotic Products Market Outlook, By Gum Health (2023-2034) ($MN)
  • Table 19 Global Oral Probiotic Products Market Outlook, By Cavity Prevention (2023-2034) ($MN)
  • Table 20 Global Oral Probiotic Products Market Outlook, By Bad Breath Management (2023-2034) ($MN)
  • Table 21 Global Oral Probiotic Products Market Outlook, By Immune Support (2023-2034) ($MN)
  • Table 22 Global Oral Probiotic Products Market Outlook, By Post-Dental Treatment Care (2023-2034) ($MN)
  • Table 23 Global Oral Probiotic Products Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 24 Global Oral Probiotic Products Market Outlook, By Pharmacies and Drug Stores (2023-2034) ($MN)
  • Table 25 Global Oral Probiotic Products Market Outlook, By Supermarkets and Hypermarkets (2023-2034) ($MN)
  • Table 26 Global Oral Probiotic Products Market Outlook, By Specialty Health Stores (2023-2034) ($MN)
  • Table 27 Global Oral Probiotic Products Market Outlook, By E-Commerce Platforms (2023-2034) ($MN)
  • Table 28 Global Oral Probiotic Products Market Outlook, By Dental Clinics (2023-2034) ($MN)
  • Table 29 Global Oral Probiotic Products Market Outlook, By Direct-to-Consumer (DTC) (2023-2034) ($MN)
  • Table 30 Global Oral Probiotic Products Market Outlook, By End User (2023-2034) ($MN)
  • Table 31 Global Oral Probiotic Products Market Outlook, By Children (2023-2034) ($MN)
  • Table 32 Global Oral Probiotic Products Market Outlook, By Adults (2023-2034) ($MN)
  • Table 33 Global Oral Probiotic Products Market Outlook, By Geriatric Population (2023-2034) ($MN)
  • Table 34 Global Oral Probiotic Products Market Outlook, By Orthodontic Patients (2023-2034) ($MN)
  • Table 35 Global Oral Probiotic Products Market Outlook, By Dental Care Patients (2023-2034) ($MN)
  • Table 36 Global Oral Probiotic Products Market Outlook, By General Consumers (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.